ONO Pharmaceutical to acquire Deciphera Pharmaceuticals in $2.4bn deal
ONO Pharmaceutical, Co., Ltd., has entered into a definitive agreement to acquire all outstanding shares of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), for $25.60 per share in cash, in a deal valued at approximately $2.4 billion. This acquisition represents a premium of 74.7% over Deciphera’s closing share price as of April 26, 2024, highlighting the strategic […]